FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973383685> ?p ?o ?g. }

• W2973383685 endingPage "3017" @default.
• W2973383685 startingPage "3009" @default.
• W2973383685 abstract "PURPOSE Population-based studies of children and adolescents with Hodgkin lymphoma (HL) report a survival disadvantage in nonwhite—non-Hispanic black (NHB) and Hispanic—patients. Whether disparities persist after adjustment for clinical and treatment-related variables is unknown. We examined survival by race/ethnicity in children receiving risk-based, response-adapted, combined-modality therapy for HL in contemporary Children’s Oncology Group trials. PATIENTS AND METHODS This pooled analysis used individual-level data from 1,605 patients (younger than age 1 to 21 years) enrolled in phase III trials for low-risk (AHOD0431), intermediate-risk (AHOD0031), and high-risk (AHOD0831) HL from 2002 to 2012. Event-free survival (EFS) and overall survival (OS) were compared between non-Hispanic white (NHW) and nonwhite patients. Cox proportional hazards for survival were estimated for both de novo and relapsed HL, adjusting for demographics, disease characteristics, and therapy. RESULTS At median follow up of 6.9 years, cumulative incidence of relapse was 17%. Unadjusted 5-year EFS and OS were 83% (SE, 1.2%) and 97% (SE, < 1%), respectively. Neither differed by race/ethnicity. In multivariable analyses for OS, nonwhite patients had a 1.88× higher hazard of death (95% CI, 1.1 to 3.3). Five-year postrelapse survival probabilities by race were as follows: NHW, 90%; NHB, 66%; and Hispanic, 80% ( P < .01). Compared with NHW, Hispanic and NHB children had 2.7-fold (95% CI, 1.2 to 6.2) and 3.5-fold (95% CI, 1.5 to 8.2) higher hazard of postrelapse mortality, respectively. CONCLUSION In patients who were treated for de novo HL in contemporary Children’s Oncology Group trials, EFS did not differ by race/ethnicity; however, adjusted OS was significantly worse in nonwhite patients, a finding driven by increased postrelapse mortality in this population. Additional studies examining treatment and survival disparities after relapse are warranted." @default.
• W2973383685 created "2019-09-26" @default.
• W2973383685 creator A5025395169 @default.
• W2973383685 creator A5029125087 @default.
• W2973383685 creator A5036356438 @default.
• W2973383685 creator A5043738456 @default.
• W2973383685 creator A5054697421 @default.
• W2973383685 creator A5059056112 @default.
• W2973383685 creator A5061910742 @default.
• W2973383685 creator A5073222794 @default.
• W2973383685 creator A5079552409 @default.
• W2973383685 creator A5089358491 @default.
• W2973383685 date "2019-11-10" @default.
• W2973383685 modified "2023-10-03" @default.
• W2973383685 title "Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children’s Oncology Group Study" @default.
• W2973383685 cites W1575457878 @default.
• W2973383685 cites W1825432510 @default.
• W2973383685 cites W1904681617 @default.
• W2973383685 cites W1920794259 @default.
• W2973383685 cites W1979006282 @default.
• W2973383685 cites W1983317938 @default.
• W2973383685 cites W1995246501 @default.
• W2973383685 cites W2018881035 @default.
• W2973383685 cites W2037994583 @default.
• W2973383685 cites W2064979424 @default.
• W2973383685 cites W2066891682 @default.
• W2973383685 cites W2094560224 @default.
• W2973383685 cites W2103443571 @default.
• W2973383685 cites W2109584286 @default.
• W2973383685 cites W2117200606 @default.
• W2973383685 cites W2120137194 @default.
• W2973383685 cites W2132646523 @default.
• W2973383685 cites W2137459751 @default.
• W2973383685 cites W2147015593 @default.
• W2973383685 cites W2158683596 @default.
• W2973383685 cites W2164955953 @default.
• W2973383685 cites W2214018624 @default.
• W2973383685 cites W2293074300 @default.
• W2973383685 cites W2559898561 @default.
• W2973383685 cites W2586677173 @default.
• W2973383685 cites W2589090458 @default.
• W2973383685 cites W2732305016 @default.
• W2973383685 cites W2765593029 @default.
• W2973383685 cites W2767762193 @default.
• W2973383685 cites W2803000479 @default.
• W2973383685 cites W2803022920 @default.
• W2973383685 cites W2890530869 @default.
• W2973383685 cites W4251930739 @default.
• W2973383685 doi "https://doi.org/10.1200/jco.19.00812" @default.
• W2973383685 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6839907" @default.
• W2973383685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31539308" @default.
• W2973383685 hasPublicationYear "2019" @default.
• W2973383685 type Work @default.
• W2973383685 sameAs 2973383685 @default.
• W2973383685 citedByCount "29" @default.
• W2973383685 countsByYear W29733836852020 @default.
• W2973383685 countsByYear W29733836852021 @default.
• W2973383685 countsByYear W29733836852022 @default.
• W2973383685 countsByYear W29733836852023 @default.
• W2973383685 crossrefType "journal-article" @default.
• W2973383685 hasAuthorship W2973383685A5025395169 @default.
• W2973383685 hasAuthorship W2973383685A5029125087 @default.
• W2973383685 hasAuthorship W2973383685A5036356438 @default.
• W2973383685 hasAuthorship W2973383685A5043738456 @default.
• W2973383685 hasAuthorship W2973383685A5054697421 @default.
• W2973383685 hasAuthorship W2973383685A5059056112 @default.
• W2973383685 hasAuthorship W2973383685A5061910742 @default.
• W2973383685 hasAuthorship W2973383685A5073222794 @default.
• W2973383685 hasAuthorship W2973383685A5079552409 @default.
• W2973383685 hasAuthorship W2973383685A5089358491 @default.
• W2973383685 hasBestOaLocation W29733836852 @default.
• W2973383685 hasConcept C120665830 @default.
• W2973383685 hasConcept C121332964 @default.
• W2973383685 hasConcept C126322002 @default.
• W2973383685 hasConcept C137403100 @default.
• W2973383685 hasConcept C143998085 @default.
• W2973383685 hasConcept C144024400 @default.
• W2973383685 hasConcept C149923435 @default.
• W2973383685 hasConcept C19165224 @default.
• W2973383685 hasConcept C207103383 @default.
• W2973383685 hasConcept C2908647359 @default.
• W2973383685 hasConcept C44249647 @default.
• W2973383685 hasConcept C50382708 @default.
• W2973383685 hasConcept C61511704 @default.
• W2973383685 hasConcept C71924100 @default.
• W2973383685 hasConcept C72563966 @default.
• W2973383685 hasConcept C88879693 @default.
• W2973383685 hasConcept C99454951 @default.
• W2973383685 hasConceptScore W2973383685C120665830 @default.
• W2973383685 hasConceptScore W2973383685C121332964 @default.
• W2973383685 hasConceptScore W2973383685C126322002 @default.
• W2973383685 hasConceptScore W2973383685C137403100 @default.
• W2973383685 hasConceptScore W2973383685C143998085 @default.
• W2973383685 hasConceptScore W2973383685C144024400 @default.
• W2973383685 hasConceptScore W2973383685C149923435 @default.
• W2973383685 hasConceptScore W2973383685C19165224 @default.
• W2973383685 hasConceptScore W2973383685C207103383 @default.
• W2973383685 hasConceptScore W2973383685C2908647359 @default.

• next